News

Grace Breeding’s Environmentally Friendly WDS Climate Stress Tolerance Solution Receives its First European Product Registration in Germany

- Grace Breeding’s WDS, a proprietary and environmentally friendly formula to counteract crop climate stress, will be marketed under the…

1 year ago

Cocrystal Pharma Selects Novel Oral Protease Inhibitor CDI-988 as Norovirus Lead

First dual coronavirus-norovirus oral antiviral is scheduled for Phase 1 in healthy volunteers In vitro studies show broad-spectrum activity against…

1 year ago

DLH to Participate in Upcoming Sidoti Micro Cap Conference

ATLANTA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and…

1 year ago

Mersana Therapeutics Announces Second Quarter 2023 Financial Results

Organization fully focused on product candidates and collaborations based on next-generation ADC platformsCapital resources expected to support current operating plan…

1 year ago

Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results

Recursion's Pipeline Recursion's internal pipeline as of Q2 2023Deployed new digital chemistry technology, together with NVIDIA, to predict the ligand-protein…

1 year ago

Tecan schedules conference call on August 15th to discuss half year 2023 financial results

Männedorf, Switzerland, August 8, 2023 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to…

1 year ago

CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update

Conference Call Scheduled for Today at 8:30 a.m. Eastern TimeBERKELEY HEIGHTS, N.J., Aug. 08, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc.…

1 year ago

Abeona Therapeutics Reports Second Quarter 2023 Financial Results

On track for Biologics License Application (BLA) submission in third quarter of 2023 Proceeds from $25 million registered direct offering…

1 year ago

Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results

MALVERN, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology…

1 year ago

XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy

Completed two royalty acquisitions in the first half of 2023 adding one cash flow generating asset, one NDA-ready asset, and…

1 year ago